Aclarion (ACON) has a profit margin of -9551.87%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for ACON is -9551.87% as of June 2026. That compares with -11110.49% in the prior-year period — up 14.0% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Aclarion's historical trend and sector peers before judging valuation or financial health.
Over the past year, ACON's profit margin moved from -11110.49% to -9551.87% — a 14.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aclarion's valuation or profitability profile.
Against Healthcare companies, ACON currently prints -9551.87% for profit margin, while the sector average sits near 13.89%. That is roughly 68852.7% below the sector mean. Large gaps often invite a closer look at Aclarion's growth, margins, and balance sheet.
Profit Margin shows how effectively Aclarion converts resources into returns. At -9551.87%, ACON may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -11110.49% in the prior-year period — up 14.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ACON's profit margin (-9551.87%), review year-over-year change from -11110.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.